The project, Colorectal Cancer Control Program Indirect/Non-Medical Cost Study (OMB No. 0920-0963, exp. 4/30/2014), received Office of Management and Budget approval, but the desired amount of information was not gathered during the initial approval period, according to the report.
The CDC is requesting a year-long extension from the OMB to collect and analyze the target amount of data.
More Articles on Gastroenterology:
Physicians at the helm: creating a culture of gastroenterologist leadership in ASCs & endoscopy centers
7 gastroenterologists making the news
Boston Scientific reports $1.87B in Q2 sales: 5 financial report highlights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
